United States · 
Who invested in Syntis Bio?
Syntis Bio's investors include National Institutes of Health, LD Capital and Safar Partners.
United States · Series A startup
Who invested in Syntis Bio
Funding summaryUpdated 26 Oct 2026
$33Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $33MJul 2025
- Investors
- 3
The rounds
- Jul 2025Series A$33M
Source recordedSEC filing: $25M sold, first sale Jun 2025
Founders and team
From Syntis Bio's own website: 4 on the team.
- Rahul DhandaChief Executive Officer
- Christo ShalishChief Business Officer
- David RosenbaumChief Development Officer
- Matt DallasChief Financial Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Syntis Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Syntis Bio
How much has Syntis Bio raised?
Syntis Bio has raised $33M across 1 round since 2025.
When did Syntis Bio last raise?
Syntis Bio's most recent round was a Series A of $33M in Jul 2025.
What was Syntis Bio's biggest round?
Its most recent round, $33M in Jul 2025, is also its largest on record.
Who backed Syntis Bio first?
Syntis Bio's first round on record, in Jul 2025, was backed by National Institutes of Health, LD Capital and Safar Partners.
What stage is Syntis Bio at?
Syntis Bio's latest named round is a Series A, in Jul 2025.
Where is Syntis Bio based?
Syntis Bio is based in the United States.
Companies like Syntis Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.